NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Absorption of therapeutic drugs by barrier gels in serum separator blood collection tubes. Volume- and time-dependent reduction in total and free drug concentrations.

Author(s): Dasgupta A, Dean R, Saldana S, Kinnaman G, McLawhon RW

Publication: Am J Clin Pathol, 1994, Vol. 101, Page 456-61

PubMed ID: 8160636 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of storage in a serum separator tube (SST) on concentrations of therapeutic drugs in serum.

Conclusion of Paper

Significant declines in the concentrations of phenytoin, phenobarbital, carbamazepine, quinidine, and lidocaine, but not salicylate or theophylline occurred within 20 min when serum was stored in Vacutainer SST. In contrast, when serum was stored in Corvac SST, only lidocaine concentrations decreased, and when serum was stored in red-top Vacutainer tubes, no significant changes in any therapeutic drug concentrations were found. The effects of storage in Vacutainer SST and Corvac SST were most dramatic when the specimen volume was small and when the specimens were stored for 48 h. The presence of protein carriers in normal serum was found to partially attenuate the effects of storage. The authors concluded that the barrier gel present in Vacutainer SST rapidly adsorbs therapeutic drugs during storage and that the effect was greatest when the volume was small or when a serum ultrafiltrate was stored.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of storage in SST and specimen volume on concentrations of therapeutic drugs in serum. Patient serum and therapeutic drug-spiked serum were used.

    Summary of Findings:

    Significant declines in the concentrations of phenytoin, phenobarbital, carbamazepine, quinidine, and lidocaine, but not salicylate or theophylline occurred within 20 min when serum was stored in Vacutainer SST. In contrast, when serum was stored in Corvac SST, only lidocaine concentrations decreased, and when serum was stored in red-top Vacutainer tubes, no significant changes in any therapeutic drug concentrations were found. The effects of storage in Vacutainer SST and Corvac SST were most dramatic when the specimen volume was small and when the specimens were stored for 48 h. The presence of protein carriers in normal serum was found to partially attenuate the effects of storage. The authors concluded that the barrier gel present in Vacutainer SST rapidly adsorbs therapeutic drugs during storage and that the effect was greatest when the volume was small or when a serum ultrafiltrate was stored.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Not specified
    • Normal
    Platform:
    AnalyteTechnology Platform
    Small molecule Immunoassay
    Small molecule Clinical chemistry/auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Type of storage container Vacutainer SST
    Corvac SST
    Red-top Vacutainer
    Storage Storage temperature 4 degrees C
    Storage Storage duration 0 min
    20 min
    40 min
    1 h
    2 h
    6 h
    24 h
    48 h
    Biospecimen Aliquots and Components Aliquot size/volume 200 ul
    300 ul
    500 ul
    750 ul
    1000 ul
    1500 ul
    Biospecimen Aliquots and Components Filtration Ultrafiltrated serum
    Normal serum

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...